|
Market Cap (2-Jul) $2,324,063,488 (333rd) |
Close (30-Jun) $1.14 |
Volume (30-Jun) 2,606,681 |
Shortsold (19-Jun) 79,324,475 (6.21%) (26th) |
|
52w High $3.37 |
52w Low $0.88 |
P/E 454.55 |
EPS -0.13 |
MSB released this announcement to the ASX on 16 January 2023, 18:36. The announcement is not marked as price sensitive, and is 25 page(s) in length and 575.59kb in size.
You can view all announcements from MSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, MSB was 4.040% short sold according to ASIC data. It was ranked the 53rd most shorted stock on the ASX. It is now ranked as the 26th most shorted stock on the ASX with 6.208% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from MSB | |
|---|---|
| Change of Director's Interest Notice | 13 June 2023, 8:56 |
| Mesoblast Director Appointed to Strategic Advisory Role | 5 June 2023, 9:41 |
| MSB Reports Q3 Financial Results and Operational Highlights | 26 May 2023, 8:32 |
| Appendix 3G, Appendix 3H and Appendix 3Ys | 16 January 2023, 18:36 |
| Biotech Showcase 2023 Presentation in San Francisco | 10 January 2023, 10:08 |
| Extension of Undrawn US$30 million Facility | 23 December 2022, 10:37 |
| Proposed issue of securities - MSB | 23 December 2022, 9:56 |
You must be logged in to post a reply.
Mesoblast 